INDEPENDENT THINKING. BETTER EVIDENCE.WEIGHT, HEALTH & THE SCIENCE BETWEEN
News

Semaglutide REMODEL: kidney clues, primary MRI limits

A 52-week mechanistic trial adds possible explanations for kidney protection, with null primary imaging results and small tissue subgroups.

Editorial evidence review ·
Two ivory ceramic pebbles, one on stacked glass discs, beside an amber bead and navy cloth.
Conceptual editorial illustration for MyWeightLab. It does not depict a medicinal product, measured trial result or treatment recommendation.

Evidence and fact-checking standards · Report a correction

Cookie policy